These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15157994)

  • 21. Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: a two-stage study.
    Myllykangas L; Wavrant-De Vrièze F; Polvikoski T; Notkola IL; Sulkava R; Niinistö L; Edland SD; Arepalli S; Adighibe O; Compton D; Hardy J; Haltia M; Tienari PJ
    J Neurol Sci; 2005 Sep; 236(1-2):17-24. PubMed ID: 16023140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complex interaction between APOE promoter and AD: an Italian case-control study.
    Bizzarro A; Seripa D; Acciarri A; Matera MG; Pilotto A; Tiziano FD; Brahe C; Masullo C
    Eur J Hum Genet; 2009 Jul; 17(7):938-45. PubMed ID: 19172988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.
    Athan ES; Williamson J; Ciappa A; Santana V; Romas SN; Lee JH; Rondon H; Lantigua RA; Medrano M; Torres M; Arawaka S; Rogaeva E; Song YQ; Sato C; Kawarai T; Fafel KC; Boss MA; Seltzer WK; Stern Y; St George-Hyslop P; Tycko B; Mayeux R
    JAMA; 2001 Nov; 286(18):2257-63. PubMed ID: 11710891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic study of Sardinian patients with Alzheimer's disease.
    Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
    Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel alternative splice variant of nicastrin and its implication in Alzheimer disease.
    Mitsuda N; Yamagata HD; Zhong W; Aoto M; Akatsu H; Uekawa N; Kamino K; Taguchi K; Yamamoto T; Maruyama M; Kosaka K; Takeda M; Kondo I; Miki T
    Life Sci; 2006 Apr; 78(21):2444-8. PubMed ID: 16303145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification and clone of human Alzheimer's disease related gene nicastrin promoter].
    Yang M; Cai F; Wang RS; Pan Q; Long ZG; Deng XY; Xia K; Xia JH; Zhang ZH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):9-13. PubMed ID: 16562666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of sex and SORL1 variants in italian patients with Alzheimer disease.
    Cellini E; Tedde A; Bagnoli S; Pradella S; Piacentini S; Sorbi S; Nacmias B
    Arch Neurol; 2009 Oct; 66(10):1260-6. PubMed ID: 19822782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease.
    Yu Y; Jia J
    Brain Res; 2009 Feb; 1257():10-5. PubMed ID: 19124009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
    Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
    Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
    Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
    Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAM10 expression and promoter haplotype in Alzheimer's disease.
    Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
    Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.
    Parra-Bonilla G; Arboleda G; Yunis J; Solano E; Pardo R; Arango G; Hedmont D; Arboleda H
    Neurosci Lett; 2003 Oct; 349(3):159-62. PubMed ID: 12951193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.
    Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Luna JL
    Neurosci Lett; 2001 May; 304(3):204-8. PubMed ID: 11343837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association study between DHCR24 polymorphisms and Alzheimer's disease.
    Lämsä R; Helisalmi S; Hiltunen M; Herukka SK; Tapiola T; Pirttilä T; Vepsäläinen S; Soininen H
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):906-10. PubMed ID: 17510943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.